Having trouble accessing articles? Reset your cache.

Forodesine: Phase II data

Top-line data from an open-label, international Phase II trial in 101 patients with stage IIB-IVA CTCL who had received >=3 prior systemic therapies showed

Read the full 245 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE